U01CA220323
Cooperative Agreement
Overview
Grant Description
Using patient-derived models to understand drug responses in SCLC.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Charlestown,
Massachusetts
021292000
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/23 to 02/29/24 and the total obligations have increased 393% from $619,923 to $3,053,683.
The General Hospital Corporation was awarded
Using patient-derived models to understand drug responses in SCLC
Cooperative Agreement U01CA220323
worth $3,053,683
from National Cancer Institute in September 2018 with work to be completed primarily in Charlestown Massachusetts United States.
The grant
has a duration of 5 years 5 months and
was awarded through assistance program 93.395 Cancer Treatment Research.
The Cooperative Agreement was awarded through grant opportunity Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01).
Status
(Complete)
Last Modified 6/20/24
Period of Performance
9/17/18
Start Date
2/29/24
End Date
Funding Split
$3.1M
Federal Obligation
$0.0
Non-Federal Obligation
$3.1M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01CA220323
Transaction History
Modifications to U01CA220323
Additional Detail
Award ID FAIN
U01CA220323
SAI Number
U01CA220323-2555939011
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
FLJ7DQKLL226
Awardee CAGE
0ULU5
Performance District
MA-07
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $3,661,510 | 100% |
Modified: 6/20/24